Adventa Bhd (XKLS:7191) EBIT : RM-8.61 Mil (TTM As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Adventa Bhd EBIT?

Adventa Bhd's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was RM0.50 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was RM-8.61 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Adventa Bhd's annualized ROC % for the quarter that ended in Mar. 2024 was 0.32%. Adventa Bhd's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 3.56%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Adventa Bhd's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -10.40%.

Adventa Bhd EBIT Historical Data

The historical data trend for Adventa Bhd's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adventa Bhd EBIT Chart

Adventa Bhd Annual Data

Trend

Oct13

Oct14

Oct15

Oct16

Oct17

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

-11.27

6.14

7.70

-4.60

-9.62

Adventa Bhd Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT	Get a 7-Day Free Trial															-0.51	-2.15	-1.59	-5.37	0.50

Competitive Comparison of Adventa Bhd's EBIT

For the Medical Instruments & Supplies subindustry, Adventa Bhd's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Adventa Bhd's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Adventa Bhd's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Adventa Bhd's EV-to-EBIT falls into.

Adventa Bhd EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was RM-8.61 Mil.

Adventa Bhd (XKLS:7191) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Adventa Bhd's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

	ROC % (Q: Mar. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Mar. 2024 ))	/ count )
=	0.236 * ( 1 - 0% )	/	( (69.133	+	77.539)	/ 2 )
=	0.236	/	73.336
=	0.32 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	105.691	-	5.195	-	( 31.363	-	max(0, 8.095	-	62.769	+	31.363	))
=	69.133

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	102.269	-	8.918	-	( 15.812	-	max(0, 9.707	-	54.38	+	15.812	))
=	77.539

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Adventa Bhd's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Mar. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	1.992	/	( ( (29.831 + max(19.509, 0))	+	(34.799 + max(27.811, 0)) )	/	2 )
=	1.992	/	( ( 49.34	+	62.61 )	/	2 )
=	1.992	/	55.975
=	3.56 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(8.648	+	12.405	+	4.483)	-	(5.195	+	0	+	0.832)
=	19.509

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(12.622	+	13.06	+	11.047)	-	(8.918	+	0	+	1.7763568394003E-15)
=	27.811

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Adventa Bhd's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2024 )
	=	-8.608	/	82.760
	=	-10.40 %

Adventa Bhd EBIT Related Terms

Thank you for viewing the detailed overview of Adventa Bhd's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Adventa Bhd (XKLS:7191) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Adventa Bhd (XKLS:7191) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 21, Jalan Tandang 51/205A, Seksyen 51, Petaling Jaya, SGR, MYS, 46050

Website

https://www.adventa.com.my

Adventa Bhd is engaged in the business of medical services and related supplies manufacturing. The company's segments include Healthcare Business, Warehousing provider, and Corporate. It generates maximum revenue from the Healthcare Business segment. The healthcare business segment comprises the supply of healthcare and related products and services to hospitals, healthcare centres, and pharmacies. Previously, it also included the renal dialysis business which are both for home and centre-based treatments, serving both the domestic and export markets. Geographically, it derives a majority of revenue from Malaysia.

Adventa Bhd (XKLS:7191) Headlines

No Headlines